StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Reaktion

Deferoxamine → 3,4-Diacetoxy-1-butene

HRID 2393487
Drucken

Reaktionsgleichung

Reaktionsgleichung von HRID 2393487
N[C@H](C(N1C(=O)N[C@H]2[C@@H]1CS[C@H]2C[CH2:13][CH2:14][CH2:15][C:16](=[O:18])O)=O)CS.[CH3:23][C:24](N(O)CCCCCNC(CCC(N(O)CCCCCNC(CCC(N(O)CCCCCN)=O)=O)=O)=O)=[O:25].CS(O)(=O)=O.[OH-].[Na+].C1C(=O)N([O:76][C:77]([CH2:79]I)=[O:78])C(=O)C1.CC(N(O)CCCCCNC(CCC(N(O)CCCCCNC(CCC(N(O)CCCCCN)=O)=O)=O)=O)=O>CO>[CH3:23][C:24]([O:13][CH2:14][CH:15]([O:78][C:77]([CH3:79])=[O:76])[CH:16]=[CH2:18])=[O:25]
KomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion

Komponenten

7

Edukt 5

HCID 2973DeferoxamineHCID 14798Sodium Hydroxide2×HCID 62881Deferoxamine MesylateHCID 3299230Iodoacetic acid N-hydroxysuccinimide esterHCID 131720825N-cysteinyl-biotin

Produkt 1

HCID 2735001
3,4-Diacetoxy-1-butene

Reagenzien, Katalysatoren, Lösungsmittel 1

HCID 887MethanolLösungsmittel

Versuchsvorschrift

DACB was synthesized by covalently conjugating iodoacetyl-deferoxamine and N-cysteinyl-biotin by the following Scheme II. ##STR20## Solid deferoxamine mesylate was added to methanol for a concentration of 20 mM, followed by addition of NaOH to reach a final concentration of 20 mM NaOH. The solution was heated and maintained at 65°. Solid iodoacetic acid N-hydroxysuccinimide ester (NHS-IA) was added to the deferoxamine solution to a final molarity of 50mM NHS-IA and incubated for at least one hour at 65°. The resulting iodoacetyl-deferoxamine (IA-DFO) was purified by HPLC with an EM LiChroCART reverse phase column using a linear gradient of 0-10 ml 100% Buffer A (0.025M phosphate, pH 6, 2 mM NTA) and 10-60 ml 0-100% Buffer B (0.025M phosphate, pH 6, 2 mM NTA, 75% methanol). IA-DFO, but not unconjugated DFO, has an absorbance at 260 nm and thus was purified by measuring the absorbance of the eluate and collecting the fraction with absorbance at 260 nm.

Aufarbeitung

  1. temperatureThe solution was heated
  2. temperaturemaintained at 65°
  3. waitincubated for at least one hour at 65°
  4. customThe resulting iodoacetyl-deferoxamine (IA-DFO) was purified by HPLC with an EM LiChroCART reverse phase column
  5. customthus was purified
  6. customcollecting the fraction with absorbance at 260 nm

Quellen und Nachweise

ORD-Eintrag
ord-51bebd3a49be48da8d6c3ecbb677d478
Quelldatensatz
uspto-grants-1998_09
DOI
10.6084/m9.figshare.5104873.v1
Patentnummer
US05807879

Notizen zur Reaktion

Auf dieser SeiteKomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion